Edition:
United Kingdom

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

7.67USD
8:23pm BST
Change (% chg)

$0.04 (+0.52%)
Prev Close
$7.63
Open
$7.59
Day's High
$7.72
Day's Low
$7.50
Volume
11,537
Avg. Vol
15,055
52-wk High
$9.56
52-wk Low
$3.60

Chart for

About

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80... (more)

Overall

Beta: 0.09
Market Cap(Mil.): $168.47
Shares Outstanding(Mil.): 21.88
Dividend: --
Yield (%): --

Financials

  APEN.OQ Industry Sector
P/E (TTM): -- 37.42 30.39
EPS (TTM): -1.74 -- --
ROI: -39.88 14.28 12.61
ROE: -71.55 17.48 14.80

BRIEF-Apollo Endosurgery Q4 Loss Per Share $0.42

* APOLLO ENDOSURGERY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

01 Mar 2018

BRIEF-Apollo Endosurgery Announces MFDS Approval For Orbera Intragastric Balloon System

* APOLLO ENDOSURGERY ANNOUNCES MFDS APPROVAL FOR ORBERA INTRAGASTRIC BALLOON SYSTEM IN SOUTH KOREA, A NON-SURGICAL SOLUTION TO ASSIST PATIENTS WITH WEIGHT LOSS Source text for Eikon: Further company coverage:

22 Feb 2018

Earnings vs. Estimates